{"id":"https://openalex.org/W7223152425","doi":"https://doi.org/10.1016/j.htct.2026.107862","title":"DISTINCT MONOCYTE STATES EMERGE DURING IMMUNE RECONSTITUTION AFTER BCMA CAR-T THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA","display_name":"DISTINCT MONOCYTE STATES EMERGE DURING IMMUNE RECONSTITUTION AFTER BCMA CAR-T THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223152425","doi":"https://doi.org/10.1016/j.htct.2026.107862"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2026.107862","doi":"https://doi.org/10.1016/j.htct.2026.107862","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107862","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1016/j.htct.2026.107862","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159161911","display_name":"Raquel GARCIA DA SILVA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raquel GARCIA DA SILVA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159203039","display_name":"Arianne FAGOTTI GUSM\u00c3O","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arianne FAGOTTI GUSM\u00c3O","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159199053","display_name":"Vanessa DOS ANJOS BOVOLENTA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vanessa DOS ANJOS BOVOLENTA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120691980","display_name":"Daniela Delechiave","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019035496","display_name":"AC Camargo Hospital","ror":"https://ror.org/03025ga79","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I3019035496"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Daniela DELECHIAVE","raw_affiliation_strings":["A.C.Camargo Cancer Center, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"A.C.Camargo Cancer Center, S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I3019035496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159165957","display_name":"Gabriel ANDRADE DE PAULA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriel ANDRADE DE PAULA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159163775","display_name":"Mariana SOARES GOMES","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariana SOARES GOMES","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159209947","display_name":"Ana Luiza SIONTI PACHECO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana Luiza SIONTI PACHECO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159175813","display_name":"Larissa CAMPOS DE SOUZA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Larissa CAMPOS DE SOUZA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159187494","display_name":"Filipe FREIRES DOS SANTOS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Filipe FREIRES DOS SANTOS","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159172149","display_name":"Ana COSTA CORDEIRO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana COSTA CORDEIRO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159201594","display_name":"Alexandre SILVA CHAVES","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandre SILVA CHAVES","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159192397","display_name":"Marta Maria MOREIRA LEMOS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marta Maria MOREIRA LEMOS","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159169753","display_name":"Marina DE MATTOS NASCIMENTO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina DE MATTOS NASCIMENTO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159179758","display_name":"Lais Lie SENDA DE ABRANTES","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lais Lie SENDA DE ABRANTES","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159203227","display_name":"Sabrina PINHO COSTA MENDES","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabrina PINHO COSTA MENDES","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012796132","display_name":"Mariela Pires Cabral Piccin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariela PIRES CABRAL PICCIN","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159180776","display_name":"Jayr SCHMIDIT FILHO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jayr SCHMIDIT FILHO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5159171399","display_name":"Marjorie VIEIRA BATISTA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marjorie VIEIRA BATISTA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.80253555,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":null,"first_page":"107862","last_page":"107862"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.4787999987602234,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.4787999987602234,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.26249998807907104,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.16439999639987946,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.921999990940094},{"id":"https://openalex.org/keywords/bcma-car-t-cell-therapy","display_name":"BCMA CAR T-cell therapy","score":0.9160000085830688},{"id":"https://openalex.org/keywords/monocyte-subsets","display_name":"monocyte subsets","score":0.6309999823570251},{"id":"https://openalex.org/keywords/hla-dr-expression","display_name":"HLA-DR expression","score":0.843999981880188},{"id":"https://openalex.org/keywords/antigen-presentation","display_name":"antigen presentation","score":0.9319999814033508},{"id":"https://openalex.org/keywords/costimulatory-molecules","display_name":"costimulatory molecules","score":0.718999981880188},{"id":"https://openalex.org/keywords/cd80","display_name":"CD80","score":0.7149999737739563},{"id":"https://openalex.org/keywords/cd86","display_name":"CD86","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nonclassical-monocytes","display_name":"non-classical monocytes","score":0.8109999895095825},{"id":"https://openalex.org/keywords/classical-monocytes","display_name":"classical monocytes","score":0.7319999933242798},{"id":"https://openalex.org/keywords/immune-reconstitution","display_name":"immune reconstitution","score":0.5929999947547913},{"id":"https://openalex.org/keywords/car-t-cell-persistence","display_name":"CAR T cell persistence","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9424999952316284},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.8284000158309937},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7009999752044678},{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.6392999887466431},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6280999779701233},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3183000087738037},{"id":"https://openalex.org/C2780648854","wikidata":"https://www.wikidata.org/wiki/Q2745824","display_name":"Immunopathology","level":2,"score":0.2962999939918518},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.22139999270439148},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.21639999747276306},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.21089999377727509}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2026.107862","doi":"https://doi.org/10.1016/j.htct.2026.107862","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107862","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:7b3b003bdbd74fc09dc43e9408b8346f","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/7b3b003bdbd74fc09dc43e9408b8346f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 48, Iss , Pp 107862- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2026.107862","doi":"https://doi.org/10.1016/j.htct.2026.107862","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107862","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7223110270","https://openalex.org/W4417018179","https://openalex.org/W7118345174","https://openalex.org/W4400773931","https://openalex.org/W4375955418","https://openalex.org/W4310107752","https://openalex.org/W4309190943","https://openalex.org/W3202498320","https://openalex.org/W4413788426","https://openalex.org/W7148766240"],"abstract_inverted_index":{"Background":[0],"Relapsed/refractory":[1],"multiple":[2],"myeloma":[3],"(RR-MM)":[4],"remains":[5],"a":[6,267,374],"major":[7],"therapeutic":[8],"challenge":[9],"despite":[10],"the":[11,181,188,334,343],"efficacy":[12],"of":[13,19,167,202,238,307,315,320,327,336,359,365,389,395],"BCMA-directed":[14,83,175,293,351],"CAR-T":[15,61,84,176,184,294,352,399],"therapy.":[16,177,400],"However,":[17],"mechanisms":[18],"innate":[20,381],"immune":[21,32,48,57,67,75,290,348,376,382,396],"reconstitution":[22,58,173,291,349,397],"remain":[23],"poorly":[24],"understood.":[25],"Monocytes":[26],"regulate":[27],"antigen":[28,142,316],"presentation,":[29,143,317],"inflammation,":[30],"and":[31,64,98,124,134,146,153,162,196,199,271,339,362],"homeostasis,":[33],"with":[34,70,79,82,141,180,192,222,356,379],"HLA-DR":[35,225,232],"reflecting":[36],"their":[37],"functional":[38,391],"state.":[39],"Characterizing":[40],"monocyte":[41,53,150,172,303,344,360,390],"phenotypes":[42],"may":[43,311,372],"provide":[44],"insights":[45],"into":[46],"post-CAR-T":[47],"recovery.":[49,304,383],"Aim":[50],"To":[51],"characterize":[52],"phenotypic":[54],"remodeling":[55,242,358],"during":[56,74],"following":[59,292,398],"BCMA":[60],"cell":[62,185],"therapy":[63,295,353],"identify":[65],"distinct":[66,337,375],"states":[68,341,392],"associated":[69,140,355,378],"impaired":[71],"antigen-presenting":[72,239,366],"profiles":[73],"reconstitution.":[76],"Methodology:":[77],"Patients":[78],"RR-MM":[80],"treated":[81],"cells":[85,106],"were":[86,92,107,128,158,274],"prospectively":[87],"enrolled.":[88],"Peripheral":[89,103],"blood":[90,104],"samples":[91],"collected":[93],"immediately":[94],"before":[95],"infusion":[96],"(baseline)":[97],"30":[99],"days":[100],"post-infusion":[101],"(D+30).":[102],"mononuclear":[105],"analyzed":[108],"by":[109,230,298],"multiparametric":[110],"flow":[111],"cytometry":[112],"using":[113],"CD45,":[114],"CD14,":[115],"CD16,":[116],"HLA-DR,":[117],"CD80,":[118],"CD86,":[119],"CD11b,":[120],"CD11c,":[121],"CD62L,":[122],"CD19,":[123],"CD56.":[125],"Monocyte":[126],"subsets":[127,361],"defined":[129],"according":[130],"to":[131],"CD14/CD16":[132],"expression":[133],"further":[135,332,387],"characterized":[136,297],"based":[137],"on":[138],"markers":[139],"activation,":[144],"co-stimulation,":[145],"migration.":[147],"Changes":[148],"in":[149],"subset":[151],"frequency":[152,186],"phenotype,":[154,213],"including":[155],"CD14\u207aHLA-DR^low/-":[156],"populations,":[157],"evaluated":[159],"between":[160],"baseline":[161,224],"D+30.":[163],"Results":[164],"Paired":[165],"analysis":[166],"three":[168],"patients":[169,221],"demonstrated":[170],"heterogeneous":[171,299],"after":[174,350],"The":[178,305],"patient":[179],"highest":[182],"circulating":[183],"exhibited":[187,280],"most":[189],"pronounced":[190],"remodeling,":[191],"reduced":[193],"total":[194],"CD14\u207a":[195],"classical":[197,207],"monocytes":[198,208,217,247,255,263,273,279,310,323,371],"relative":[200],"expansion":[201],"non-classical":[203,254,262,278,322,370],"monocytes.":[204],"Across":[205],"patients,":[206],"shifted":[209],"toward":[210],"an":[211],"HLA-DR-intermediate":[212],"while":[214,277],"HLA-DR-negative":[215,308],"intermediate":[216,246,272,309],"consistently":[218],"decreased.":[219],"In":[220],"low":[223],"expression,":[226],"this":[227],"was":[228,243],"accompanied":[229],"increased":[231,249,257],"fluorescence":[233],"intensity,":[234],"suggesting":[235],"partial":[236,313,363],"restoration":[237,314],"capacity.":[240],"Co-stimulatory":[241],"subset-specific:":[244],"HLA-DR\u207a":[245,253],"showed":[248],"CD80\u207aCD86\u207b":[250],"cells,":[251],"whereas":[252,318],"displayed":[256],"CD80\u207bCD86\u207a":[258],"cells.":[259],"Residual":[260],"HLA-DR\u207b":[261,369],"remained":[264],"enriched":[265],"for":[266],"CD80\u207bCD86\u207b":[268],"phenotype.":[269],"Classical":[270],"predominantly":[275],"CD11b\u207aCD11c\u207a,":[276],"greater":[281],"CD11b/CD11c":[282,330],"heterogeneity.":[283],"Discussion:":[284],"These":[285,384],"findings":[286,385],"suggest":[287,324],"that":[288],"early":[289],"is":[296,354],"rather":[300],"than":[301],"uniform":[302],"reduction":[306],"indicate":[312],"persistence":[319],"HLA-DR\u207bCD80\u207bCD86\u207b":[321],"incomplete":[325,380],"recovery":[326,364],"co-stimulatory":[328],"function.":[329],"heterogeneity":[331],"supports":[333],"existence":[335],"activation":[338],"migratory":[340],"within":[342],"compartment.":[345],"Conclusion":[346],"Early":[347],"dynamic":[357],"phenotypes.":[367],"Persistent":[368],"represent":[373],"state":[377],"support":[386],"investigation":[388],"as":[393],"biomarkers":[394]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-22T00:00:00"}